發(fā)布時(shí)間：2018-10-08 08:22

【摘要】：正近期,全球各大網(wǎng)站紛紛刊載一個(gè)重磅新聞:全球首臺(tái)可用于臨床的7T磁共振MAGNETOM Terra已經(jīng)正式取得CE認(rèn)證,可以用于臨床!因?yàn)?T具有巨大的潛力,已經(jīng)正在改變、未來(lái)也必然會(huì)繼續(xù)改變整個(gè)磁共振成像發(fā)展的方向。多年來(lái)的研究已經(jīng)證實(shí),7T提供了數(shù)倍于傳統(tǒng)3T磁共振的信噪比和空間分辨率,在神經(jīng)、血管、腫瘤、骨關(guān)節(jié)等多個(gè)方面都會(huì)帶來(lái)全新的突破性進(jìn)展。尤其是在目前常規(guī)影像設(shè)備難以診斷的神經(jīng)退行性疾病
[Abstract]:Recently, the world's major websites have published a big news: the world's first 7T magnetic resonance MAGNETOM Terra can be used for clinical applications have been officially certified CE, can be used in clinical! Because 7T has great potential, it is changing, and will continue to change the whole direction of MRI. Over the years, it has been proved that T7T provides a signal-to-noise ratio (SNR) and spatial resolution multiple times that of conventional 3T MRI, and will bring new breakthroughs in nerve, blood vessel, tumor, bone and joint, and so on. Especially the neurodegenerative diseases which are difficult to diagnose by conventional imaging equipment at present.
【分類號(hào)】：+

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 高凱;張連峰;;PET/CT影像技術(shù)在神經(jīng)退行性疾病動(dòng)物模型研究中的應(yīng)用[J];中國(guó)比較醫(yī)學(xué)雜志;2009年06期

相關(guān)會(huì)議論文 前1條

1 吳敏;張海平;劉承宜;;SIRT2:運(yùn)動(dòng)治療神經(jīng)退行性疾病的新興靶點(diǎn)[A];2013年中國(guó)生理學(xué)會(huì)運(yùn)動(dòng)生理學(xué)專業(yè)委員會(huì)年會(huì)暨“運(yùn)動(dòng)與健康”學(xué)術(shù)研討會(huì)論文摘要匯編[C];2013年

，

本文編號(hào)：2256085